HER2-Positive Gastric Cancer

被引：0
|
作者：
Haralabos Demetriades
机构：
[1] Aristotle University of Thessaloniki,4th Surgical Department
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Gastric Cancer; Trastuzumab; Gastric Cancer Patient; Adjuvant Setting; HER2 Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：1
相关论文
共 50 条
  • [21] Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
    Oh, Do-Youn
    Lee, Kewn-Wook
    Cho, Jae Yong
    Kang, Won Ki
    Im, Seock-Ah
    Kim, Jin Won
    Bang, Yung-Jue
    GASTRIC CANCER, 2016, 19 (04) : 1095 - 1103
  • [22] Second line of treatment for HER2-positive gastric cancer: an evolving issue
    Roviello, Giandomenico
    Catalano, Martina
    D'Angelo, Alberto
    Palmieri, Valeria Emma
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (02) : 316 - 317
  • [23] Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab
    Diaz-Serrano, Asuncion
    Angulo, Barbara
    Dominguez, Carolina
    Pazo-Cid, Roberto
    Salud, Antonieta
    Jimenez-Fonseca, Paula
    Leon, Ana
    Carmen Galan, Maria
    Alsina, Maria
    Rivera, Fernando
    Plaza, J. Carlos
    Paz-Ares, Luis
    Lopez-Rios, Fernando
    Gomez-Martin, Carlos
    ONCOLOGIST, 2018, 23 (09) : 1092 - 1102
  • [24] Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Namba, Kei
    Torigoe, Hidejiro
    Sato, Hiroki
    Tomida, Shuta
    Yamamoto, Hiromasa
    Asano, Hiroaki
    Soh, Junichi
    Tsukuda, Kazunori
    Nagasaka, Takeshi
    Fujiwara, Toshiyoshi
    Toyooka, Shinichi
    CANCER SCIENCE, 2018, 109 (04) : 1166 - 1176
  • [25] Recent Progress in Treatment for HER2-Positive Advanced Gastric Cancer
    Kawakami, Takeshi
    Yamazaki, Kentaro
    CANCERS, 2024, 16 (09)
  • [26] HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments
    Scheck, Magdalena K.
    Hofheinz, Ralf D.
    Lorenzen, Sylvie
    CANCERS, 2024, 16 (07)
  • [27] Clinicopathological features and endoscopic findings of HER2-positive gastric cancer
    Yasuhiro Oono
    Takeshi Kuwata
    Kenji Takashima
    Yusuke Yoda
    Hiroaki Ikematsu
    Kohei Shitara
    Takahiro Kinoshita
    Tomonori Yano
    Surgical Endoscopy, 2018, 32 : 3964 - 3971
  • [28] Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
    Kotani, Daisuke
    Shitara, Kohei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [29] Trastuzumab in HER2-Positive Metastatic Gastric CancerProfile Report
    Jamie D. Croxtall
    Kate McKeage
    BioDrugs, 2011, 25 : 257 - 259
  • [30] Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy
    Urabe, Masayuki
    Ushiku, Tetsuo
    Seto, Yasuyuki
    Fukayama, Masashi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (10) : 1326 - 1333
12345